0
13

In This Issue
  |  
The American Journal of Psychiatry

June 01, 2001, Vol. 158, No. 6
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Editorial
New Concepts for Prevention and Treatment of Late-Life Depression
George S. Alexopoulos, M.D.
Reviews and Overviews
Successful Aging
George E. Vaillant, M.D.; Kenneth Mukamal, M.D.
How Do Risk Factors Work Together? Mediators, Moderators, and Independent, Overlapping, and Proxy Risk Factors
Helena Chmura Kraemer, Ph.D.; Eric Stice, Ph.D.; Alan Kazdin, Ph.D.; David Offord, M.D.; David Kupfer, M.D.
Depression in the Planet’s Largest Ethnic Group: The Chinese
Gordon Parker, D.Sc., M.D., Ph.D., F.R.A.N.Z.C.P.; Gemma Gladstone, B.A. (Hons); Kuan Tsee Chee, D.P.M., F.A.M.S., M.R.C.Psych.
Article
Syndromic Validity of Apathy in Alzheimer’s Disease
Sergio E. Starkstein, M.D., Ph.D.; Gustavo Petracca, M.D.; Erán Chemerinski, M.D.; Janus Kremer, M.D.
Relationship of Deep White Matter Hyperintensities and Apolipoprotein E Genotype to Depressive Symptoms in Older Adults Without Clinical Depression
Robert D. Nebes, Ph.D.; Illa J. Vora, B.S.; Carolyn C. Meltzer, M.D.; Melanie B. Fukui, M.D.; Robert L. Williams, M.D.; M. Ilyas Kamboh, Ph.D.; Judith Saxton, Ph.D.; Patricia R. Houck, M.S.; Steven T. DeKosky, M.D.; Charles F. Reynolds, III, M.D.
The Interplay and Etiological Continuity of Neuroticism, Difficulties, and Life Events in the Etiology of Major and Subsyndromal, First and Recurrent Depressive Episodes in Later Life
Johan Ormel, Ph.D.; Albertine J. Oldehinkel, Ph.D.; Els I. Brilman, M.A.
Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip Fracture
Philip S. Wang, M.D., Dr.P.H.; Rhonda L. Bohn, Sc.D.; Robert J. Glynn, Sc.D., Ph.D.; Helen Mogun, M.S.; Jerry Avorn, M.D.
Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression
Sidney H. Kennedy, M.D., F.R.C.P.(C.); Kenneth R. Evans, Ph.D.; Stephanie Krüger, M.D.; Helen S. Mayberg, M.D., F.R.C.P.(C.); Jeffrey H. Meyer, M.D., F.R.C.P.(C.); Sonia McCann, B.Sc.; Andrew I. Arifuzzman, B.A.; Sylvain Houle, M.D., Ph.D.; Franco J. Vaccarino, Ph.D.
Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression
Charles B. Nemeroff, M.D., Ph.D.; Dwight L. Evans, M.D.; Laszlo Gyulai, M.D.; Gary S. Sachs, M.D.; Charles L. Bowden, M.D.; Ivan P. Gergel, M.D., M.B.A.; Rosemary Oakes, M.S.; Cornelius D. Pitts, R.Ph.
Familiality of the Puerperal Trigger in Bipolar Disorder: Results of a Family Study
Ian Jones, M.R.C.Psych.; Nick Craddock, Ph.D., M.R.C.Psych.
Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment
Jeremy M. Crook, Ph.D.; Eva Tomaskovic-Crook, B.Sc.(Hons.); David L. Copolov, M.B.B.S., Ph.D.; Brian Dean, Ph.D.
No Support for Regional Selectivity in Clozapine-Treated Patients: A PET Study With [11C]Raclopride and [11C]FLB 457
Mirjam Talvik, M.D.; Anna-Lena Nordström, M.D., Ph.D.; Svante Nyberg, M.D., Ph.D.; Hans Olsson, M.D.; Christer Halldin, Ph.D.; Lars Farde, M.D., Ph.D.
Impact of Clozapine on Completed Suicide
Michael J. Sernyak, M.D.; Rani Desai, Ph.D.; Marilyn Stolar, M.A.; Robert Rosenheck, M.D.
A Functional Magnetic Resonance Imaging Study of Auditory Mismatch in Schizophrenia
Cynthia G. Wible, Ph.D.; Marek Kubicki, M.D., Ph.D.; Seung-Schik Yoo, Ph.D.; Daniel F. Kacher, M.S.; Dean F. Salisbury, Ph.D.; Mark C. Anderson, M.S.; Martha E. Shenton, Ph.D.; Yoshio Hirayasu, M.D., Ph.D.; Ron Kikinis, M.D.; Ferenc A. Jolesz, M.D.; Robert W. McCarley, M.D.
Intact Implicit Learning in Schizophrenia
Jean-Marie Danion, M.D.; Thierry Meulemans, M.D.; Françoise Kauffmann-Muller, M.Sc.; Hester Vermaat
Clinical Case Conference
Treatment of a 50-Year-Old African American Woman Whose Chronic Posttraumatic Stress Disorder Went Undiagnosed for Over 20 Years
Alice L. Cooke, L.S.W.; M. Katherine Shear, M.D.
Brief Report
Plasma Protein and Lipoprotein Distribution of Clozapine
Ric M. Procyshyn, Ph.D.; Nathan B. Kennedy; Samantha Marriage; Kishor M. Wasan, Ph.D.
Morphometry of Individual Cerebellar Lobules in Schizophrenia
Russell T. Loeber, B.S.; Christina M.B. Cintron, B.S.; Deborah A. Yurgelun-Todd, Ph.D.
Test-Retest Reliability of a Functional MRI Working Memory Paradigm in Normal and Schizophrenic Subjects
Dara S. Manoach, Ph.D.; Elkan F. Halpern, Ph.D.; Todd S. Kramer, B.S.; Yuchiao Chang, Ph.D.; Donald C. Goff, M.D.; Scott L. Rauch, M.D.; David N. Kennedy, Ph.D.; Randy L. Gollub, M.D., Ph.D.
Cerebral Phosphate Metabolism in First-Degree Relatives of Patients With Schizophrenia
Silke Klemm, Ph.D.; Reinhard Rzanny, Ph.D.; Stephan Riehemann, Ph.D.; Hans-Peter Volz, M.D.; Beate Schmidt, M.D.; Uwe-Jens Gerhard, M.D.; Christina Filz, M.A.; Anke Schönberg; Hans-Joachim Mentzel, M.D.; Werner A. Kaiser, M.D.; Bernhard Blanz, M.D.
The One-Child Family and Violent Criminality: A 31-Year Follow-Up Study of the Northern Finland 1966 Birth Cohort
Liisa Kemppainen, M.D.; Jari Jokelainen, M.Sc.; Marjo-Riitta Järvelin, M.D., Ph.D.; Matti Isohanni, M.D., Ph.D.; Pirkko Räsänen, M.D., Ph.D.
Letter to the Editor
PANDAS Variant and Body Dysmorphic Disorder
SANJAY J. MATHEW, M.D.
Treatment of Anorexia Nervosa With Tramadol
SCOTT D. MENDELSON, M.D., PH.D.
Mania and Tramadol-Fluoxetine Combination
ANA GONZALEZ-PINTO, M.D.; HARKAITZ IMAZ, M.D.; JOSE LUIS PÉREZ DE HEREDIA, M.D.; MIGUEL GUTIERREZ, M.D.; JUAN ANTONIO MICÓ, M.D.
Tramadol Dependence With No History of Substance Abuse
WILLIAM R. YATES, M.D.; MAI H. NGUYEN, M.D.; JULIA K. WARNOCK, M.D., PH.D.
Gabapentin for Behavioral Dyscontrol With Mental Retardation
VASILIS BOZIKAS, M.D.; FRANCESCA BASCIALLA, M.D.; PANAYOTIS YULIS, M.D.; IOANNA SAVVIDOU, M.D.; ATHANASIOS KARAVATOS, M.D., PH.D.
Cataracts and Quetiapine
FAKHRUDIN VALIBHAI, PHARM.D.; NGU B. PHAN, PHARM.D.; DANIEL J. STILL, PHARM.D., B.C.P.P.; JANET TRUE, M.D.
SSRI Discontinuation and Buspirone
ENRIQUE J. CARRAZANA, M.D.; RAFAEL A. RIVAS-VAZQUEZ, PSY.D.; JOSÉ A. REY, PHARM.D.; GUSTAVO J. REY, PH.D.
SSRIs and Mammoplasia
PAULA MARCUS, M.D.
Topiramate for Binge-Eating Disorder
JOSÉ C. APPOLINARIO, M.D.; WALMIR COUTINHO, M.D.; LEONARDO FONTENELLE, M.D.
Control of Tourette’s Syndrome With Topiramate
F.S. ABUZZAHAB, SR., M.D., PH.D.; VICTORIA L. BROWN
Topiramate for Clozapine-Induced Seizures
VICTOR NAVARRO, M.D.; ALEX PONS, M.D.; ANA ROMERO, PH.D.; MIGUEL BERNARDO, M.D., PH.D.
Possible Interaction of Clozapine and Lisinopril
GEORGE ABRAHAM, M.D.; BEATRICE GRUNBERG, M.D.; SYLVIA GRATZ, M.D.
Modafinil for Narcolepsy
EDWARD TEITELMAN, M.D.
Psychosis After Ultrarapid Opiate Detoxification
S.S. SHREERAM, M.D.; TIMOTHY McDONALD, M.D., J.D.; SYLVIA DENNISON, M.D.
Cognitive Behavior Therapy for Weight Gain
DANIEL UMBRICHT, M.D.; HEIDI FLURY, M.A.; RENÉ BRIDLER, M.D.
Dopamine D2 Receptor Blockade in Schizophrenia
RODRIGO A. BRESSAN, M.D., M.PHIL.; HUGH M. JONES, M.R.C.PSYCH.; PETER J. ELL, M.D., M.SC., P.D., F.R.C.R., F.R.C.P.; LYN S. PILOWSKY, PH.D., M.R.C.PSYCH.
5-HT1D Function and Repetitive Behaviors
ERIC HOLLANDER, M.D.; STEFANO PALLANTI, M.D., PH.D.
Dr. de Haan and Colleagues Reply
LIEUWE DE HAAN, M.D.; JULES LAVALAYE, M.D.; DON LINSZEN, M.D., PH.D.; PETER M.A.J. DINGEMANS, PH.D.; JAN BOOIJ, M.D., PH.D.
Dr. Mundo and Colleagues Reply
EMANUELA MUNDO, M.D.; MARGARET A. RICHTER, M.D.; FARIBA SAM, B.SC.; FABIO MACCIARDI, M.D.; JAMES L. KENNEDY, M.D.
ECT Failure Rate Among Specific Devices
CONRAD M. SWARTZ, PH.D., M.D.
Antidepressant Use by Race
HELEN C. KALES, M.D.; FREDERIC C. BLOW, PH.D.; ALAN M. MELLOW, M.D., PH.D.
Drs. Krystal and Weiner Reply
ANDREW D. KRYSTAL, M.D., M.S.; RICHARD D. WEINER, M.D., PH.D.
Dr. Blazer and Colleagues Reply
DAN G. BLAZER, M.D., PH.D.; CELIA HYBELS, PH.D.; ELEANOR SIMONSICK, PH.D.; JOE T. HANLON, PHARM.D.
Dysthymia and Comorbid Disorders
JAMES A. BOURGEOIS, M.D.
Dr. Klein Replies
DANIEL N. KLEIN, PH.D.
Book Forum: CHILD PSYCHIATRY
Your Child: What Every Parent Needs to Know: What’s Normal, What’s Not, and When to Seek Help
LAWRENCE HARTMANN, M.D.
Attachment Disorganization
WILLIAM M. KLYKYLO, M.D.
Treatment of Childhood Disorders, 2nd ed.
TRUCE T. ORDOÑA, M.D.
A Handbook of Integrative Psychotherapies for Children and Adolescents
LESLIE M. LOTHSTEIN, PH.D.
Book Forum: Religion and Ethics
Spirituality, Ethics, and Relationships in Adulthood: Clinical and Theoretical Explorations
ARMANDO R. FAVAZZA, M.D., M.P.H.
Satanism: Psychiatric and Legal Views
MARVIN W. ACKLIN, PH.D.
The Reproduction of Evil: A Clinical and Cultural Perspective
MICHAEL H. STONE, M.D.
Book Forum: History: Changes and Challenges
American Psychiatry After World War II: 1944–1994
HOWARD S. SUDAK, M.D.
Of Two Minds: The Growing Disorder in American Psychiatry
RONALD O. RIEDER, M.D.
Book Forum: Social Issues
Abortion: Facts and Feelings
ELISSA P. BENEDEK, M.D.
Race and Excellence: My Dialogue With Chester Pierce
GEORGE BUSH, M.D., M.M.SC.
Images In Neuroscience
The Human Genome: Susceptibility Loci
Wade H. Berrettini, M.D., Ph.D.
Images in Psychiatry
Moral Treatment at the End of the Oregon Trail: Dr. James C. Hawthorne, 1819–1881
David L. Cutler, M.D.
Correction
Correction
  |  
Copyright ©
American
Psychiatric
Association